Literature DB >> 15532718

Regulation of protein kinase C isozymes in volume overload cardiac hypertrophy.

Martin U Braun1, Paul LaRosée, Gregor Simonis, Mathias M Borst, Ruth H Strasser.   

Abstract

Protein kinase C (PKC) is a family of at least 11 isozymes and known to play a crucial role in myocardial growth. The present study was performed to investigate whether PKC-isozymes are differentially regulated during the development of volume-overload cardiac hypertrophy. After 2, 7 and 30 days of sham or aortocaval shunt operation in male Wistar rats, PKC-activity and the expression of cardiac PKC-isozymes (PKC-alpha, delta and epsilon) were determined at the protein and at the mRNA-level in the left and the right ventricle separately. Myocardial hypertrophy after 2, 7 and 30 days of aortocaval shunt was more pronounced in the right than in the left ventricle. Right ventricular hypertrophy was associated with an increased PKC-enzyme activity, a selectively enhanced protein expression of cytosolic PKC-delta (day 7: +83 +/- 12%, day 30: +94 +/- 14%) and PKC-alpha (day 7: +48 +/- 11%, day 30: +62 +/- 16%) and a transcriptional upregulation of the absolute mRNA-levels of these PKC-isozymes in the aortocaval shunt group as compared to controls. In contrast, the expression of PKC-epsilon was unchanged. A significant upregulation of PKC-delta both on the protein and on the mRNA-level was also noted in volume-overload induced left ventricular hypertrophy, whereas the expression of PKC-alpha and PKC-epsilon were not altered. Furthermore, the expression of calcineurin in both ventricles was not significantly changed in response to volume-overload. This study characterizes in the left and right ventricle a differential regulation of the dominant PKC-isozymes in volume-overload cardiac hypertrophy both at the protein and at the mRNA-level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15532718     DOI: 10.1023/b:mcbi.0000038229.23132.9f

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

1.  A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function.

Authors:  J A Johnson; M O Gray; C H Chen; D Mochly-Rosen
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

2.  Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes.

Authors:  M Pucéat; R Hilal-Dandan; B Strulovici; L L Brunton; J H Brown
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

3.  The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system : relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes.

Authors:  K C Wollert; J Heineke; J Westermann; M Lüdde; B Fiedler; W Zierhut; D Laurent; M K Bauer; K Schulze-Osthoff; H Drexler
Journal:  Circulation       Date:  2000-03-14       Impact factor: 29.690

Review 4.  Molecular basis of cardiac hypertrophy.

Authors:  T Yamazaki; Y Yazaki
Journal:  Z Kardiol       Date:  2000-01

Review 5.  Signalling pathways in cardiac myocyte hypertrophy.

Authors:  P H Sugden
Journal:  Ann Med       Date:  2001-12       Impact factor: 4.709

6.  Two distinct mechanisms mediate a differential regulation of protein kinase C isozymes in acute and prolonged myocardial ischemia.

Authors:  R H Strasser; G Simonis; S P Schön; M U Braun; R Ihl-Vahl; C Weinbrenner; R Marquetant; W Kübler
Journal:  Circ Res       Date:  1999-07-09       Impact factor: 17.367

7.  Classical, novel and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes.

Authors:  J B Decock; J Gillespie-Brown; P J Parker; P H Sugden; S J Fuller
Journal:  FEBS Lett       Date:  1994-12-19       Impact factor: 4.124

8.  Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane.

Authors:  A S Kraft; W B Anderson
Journal:  Nature       Date:  1983 Feb 17-23       Impact factor: 49.962

9.  Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat.

Authors:  X Gu; S P Bishop
Journal:  Circ Res       Date:  1994-11       Impact factor: 17.367

10.  Arachidonic acid stimulates protein kinase C-epsilon redistribution in heart cells.

Authors:  X P Huang; Y Pi; A J Lokuta; M L Greaser; J W Walker
Journal:  J Cell Sci       Date:  1997-07       Impact factor: 5.285

View more
  12 in total

1.  Conditional knockout of activin like kinase-1 (ALK-1) leads to heart failure without maladaptive remodeling.

Authors:  Kevin J Morine; Xiaoying Qiao; Vikram Paruchuri; Mark J Aronovitz; Emily E Mackey; Lyanne Buiten; Jonathan Levine; Keshan Ughreja; Prerna Nepali; Robert M Blanton; Richard H Karas; S Paul Oh; Navin K Kapur
Journal:  Heart Vessels       Date:  2017-02-17       Impact factor: 2.037

2.  Hypertrophy signaling pathways in experimental chronic aortic regurgitation.

Authors:  Niels Thue Olsen; Veronica L Dimaano; Thomas Fritz-Hansen; Peter Sogaard; Khalid Chakir; Kristian Eskesen; Charles Steenbergen; David A Kass; Theodore P Abraham
Journal:  J Cardiovasc Transl Res       Date:  2013-07-26       Impact factor: 4.132

Review 3.  Update on novel targets and potential treatment avenues in pulmonary hypertension.

Authors:  John C Huetsch; Karthik Suresh; Meghan Bernier; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-02       Impact factor: 5.464

4.  PKC δ and βII regulate angiotensin II-mediated fibrosis through p38: a mechanism of RV fibrosis in pulmonary hypertension.

Authors:  Havovi Chichger; Alexander Vang; Kelly A O'Connell; Peng Zhang; Ulrike Mende; Elizabeth O Harrington; Gaurav Choudhary
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-02-06       Impact factor: 5.464

5.  Role of protein kinase C-delta in angiotensin II induced cardiac fibrosis.

Authors:  Vishnu Chintalgattu; Laxmansa C Katwa
Journal:  Biochem Biophys Res Commun       Date:  2009-06-18       Impact factor: 3.575

6.  PKC translocation and ERK1/2 activation in compensated right ventricular hypertrophy secondary to chronic emphysema.

Authors:  Erick Avelar; Thunder Jalili; Li Dong; Joel Arvizo; Ping Hu; Sheldon E Litwin; John P Mattson
Journal:  BMC Physiol       Date:  2005-05-05

Review 7.  Protein Kinases as Drug Development Targets for Heart Disease Therapy.

Authors:  Naranjan S Dhalla; Alison L Müller
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-05

8.  Sildenafil treatment attenuates ventricular remodeling in an experimental model of aortic regurgitation.

Authors:  Kristian Eskesen; Niels Thue Olsen; Veronica L Dimaano; Thomas Fritz-Hansen; Peter Sogaard; Khalid Chakir; Charles Steenbergen; David Kass; Theodore P Abraham
Journal:  Springerplus       Date:  2015-10-13

9.  Role of PKCδ in Enhanced Expression of Gqα/PLCβ1 Proteins and VSMC Hypertrophy in Spontaneously Hypertensive Rats.

Authors:  Mohammed Emehdi Atef; Madhu B Anand-Srivastava
Journal:  PLoS One       Date:  2016-07-05       Impact factor: 3.240

10.  Protein kinase C isozyme expression in right ventricular hypertrophy induced by pulmonary hypertension in chronically hypoxic rats.

Authors:  Chao Zeng; Bin Liang; Rui Jiang; Yiwei Shi; Yongcheng Du
Journal:  Mol Med Rep       Date:  2017-07-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.